NASD Securities licensing product series 7, series 6, series 63, series 9,series 10,series 66, series 65, series 62, series 55, series 26 & series 24,securities licensing,obtaining securities license, securities books

These are samples - we have online courses, software only, books only and combos. Go to NASD Securities & License CE for complete details, sample chapters & exam questions .

Or if you want to check prices or sign up

Series 7: General Securities Representative Online

Qualifies an individual to solicit, purchase, and/or sell all securities products, including corporate securities, municipal securities, municipal fund securities, options, direct participation programs, investment company products, and variable contracts.

Series 63: Uniform Sec Agent State Law Exam Book & Software

The examination covers the principles of state securities regulation reflected in the Uniform Securities Act; these laws are sometimes called "Blue Sky" laws.

Series 6: Textbook

Qualifies an individual to sell investment company securities, mutual funds, variable annuities, and variable life insurance products. NASD Securities licensing product series

Series 9: General Securities Sales Supervisor - Options

Qualifies an individual to register as a principal to supervise sales activities in corporate, municipal, and options securities, investment company products, variable contracts, and direct participation programs.

Series 10: Gen Securities Sales Supervisor/Book/Exam Software

Series 9 &10 General Securities Sales Supervisor

Series 9: General Securities Sales Supervisor - Options

Series 10: General Securities Sales Supervisor - General Securities

Series 7&63General Securities Rep/Online

Series 7: General Securities Representative

Series 63: Uniform Securities Agent State Law Examination

The examination covers the principles of state securities regulation reflected in the Uniform Securities Act; these laws are sometimes called "Blue Sky" laws.

NASD Securities licensing product series

Series 66: Uniform Combined State Law Examination

Qualifies an individual to be both an "agent" of a broker/dealer and an "investment advisor" representative in each state. NASD Securities licensing product series

Series 65: Uniform Investment Advisor Law Examination

Qualifies a representative to act as an investment advisor and receive a fee.

Series 62: Corporate Securities Limited Representative

Qualifies an individual to sell public offerings and/or private placements of corporate stocks, corporate bonds, rights, warrants, REITs, CMOs, and securities of closed-end companies, repos and certificates of accrual on corporate securities; securities traders; M&A; venture capital; corporate financing; ETFs, and hedge funds. NASD Securities licensing product series

Series 6&63 Inv Co Pro/Uniform Securities Agent State Law Exam

Series 6: Investment Company Products/Variable Contract Representative

Qualifies an individual to sell investment company securities, mutual funds, variable annuities, and variable life insurance products.

Series 63: Uniform Securities Agent State Law Examination

The examination covers the principles of state securities regulation reflected in the Uniform Securities Act; these laws are sometimes called "Blue Sky" laws.

Series 55: Equity Trader Limited Representative

Qualifies an individual to trade equity and convertible debt securities on a principal or agency basis.

Series 26: Investment Co Products/Variable Contracts Limited Prin

Qualifies an individual to supervise the sale of investment company securities and variable contracts. NASD Securities licensing product series

Series 24: General Securities Principal

Qualifies an individual to be an officer, partner, or supervisor of sales personnel with a FINRA member firm.

Securities and Futures Prep

NASD Securities licensing product series for investment, financial services, stocks and bonds for stockbroker training

Series 6, 7, 9, 10, 24, 26, 55, 62, 63, 65, and 66 instruction now available

Packages, courses, books, and software! Prices range from $60 through $279

Become a stock broker!

These are just samples - we have online courses, software only, books only and combos. Go to NASD Securities & License CE for complete details, sample chapters & exam questions or to the sign up catalog page for descriptions and prices.

Our online training courses can't be beat. Also our online certification classes are the best you can find anywhere.

Many, many demos to choose from

NASD Securities licensing product series for investment, financial services, stocks and bonds for stockbroker training

Many more courses -To view entire course catalog or to ENROLL

For Help call 877.230.9485

We offer support 7 days a week, 24 hours a day

SAMPLE

Series 7 (General Securities Representative Examination)

COURSE DESCRIPTION:

The Series 7 exam is required by most broker-dealers for their registered representatives. General Securities Registered Representative license entitles the holder to to sell all types of securities products, with the exception of commodities futures (which requires a Series 3 license). This course will prepare you for the Series 7 Exam by covering areas tested by the NASD. Series 7 serves as a prerequisite for most of the NASDs principals examinations and is the most comprehensive of the NASD representative licenses.

This course covers the solicitation, purchase, and/or sale of a broad range of investment products, including stocks, bonds, mutual funds, municipal securities, options, and direct participation programs. This course also examines areas such as options, debt securities, taxes, investment banking, financial statements, law, NASD, investment companies, municipal securities, trading, margin, securities analysis, economics, and self-regulatory organizations (SROs).

Each section will be followed by quizzes and then a practice quiz on each topic will be given to sharpen test-taking skills. Feedback rationale is offered for each question that clarifies and improves retention. Database of over 1200 questions and finals that simulate the actual NASD exam will help to ensure exam readiness. Study emphasis should be placed on the quizzes and final exams: successful completion of the quizzes will be benchmarks indicating your progress in preparation for the license exam.

LEARNING OBJECTIVES:

• Learn the general characteristics of equity securities, which include various aspects of stocks and government securities, rights and warrants, computations of interest, yield and price; learn how to make recommendations to customers.

• Understand the economics of the business cycle, effects of inflation, investment analysis, currency markets and exchange rates. Learn about the money market and the sources of economic and business performance data.

• Learn about the various types of customer accounts, their management by third parties, and how and why accounts are closed or transferred. Understand the calculations required for margin accounts and learn about short sales.

• Understand trading, which includes various types of orders, the consolidated tape and how to collect information on stocks and bonds.

• Understand the general characteristics of municipal securities, their types and marketability. Learn the methods of underwriting and the analysis of bonds.

• Understand the purpose and types of investment companies, the types of mutual funds and their marketing, and the rules and legalities of investment companies.

TOPICS COVERED:

• Introduction

• LESSON 1: Securities

• LESSON 2: Economics

• LESSON 3: Margin

• LESSON 4: Trading

• LESSON 5: Municipal Securities

• LESSON 6: Investment Companies

• LESSON 7: NASD

• LESSON 8: Law

• LESSON 9: Financial Statements

• LESSON 10: Taxes

• LESSON 11: Direct Participation Programs

• LESSON 12: Options

COURSE PRACTICE TESTS:

To help prepare you for the licensing examination, at the end of the course, you will have the option of taking an unlimited number of practice examinations, each consisting of 100 questions. You will be able to take the practice exams an unlimited number of times.

SEAT TIME:

This course takes approximately 60-80 hours to review all of the content.

ACCESS TO COURSE:

From the date of purchase, you will have access to the course for 120 days.

LICENSING EXAMINATION:

Below is information regarding the licensing examination administered by the NASD. For additional information please to to www.nasd.org.

COURSE PRE-REQUISITE:

There is no pre-requisite to take this exam.

EXAM TIME:

Applicants are allowed 6 hours to complete the exam.

Stocks extend advance

Better-than-expected results from GE, Citi and Google help Wall Street gain on session. Stocks stretch run to 6 weeks.

Last Updated: April 17, 2009: 5:49 PM ET

ROAD TO RESCUE

Wall Street: Plan for a storm

Volcker: Recovery will be a 'long slog'

Show-me a bank failure: Missouri bank is no.24

Fannie Mae CEO takes over TARP

Bank of America has plenty to prove

Quick Vote

If you were a venture capitalist, which field would you invest in this year?

Green energyConsumer productsITFinancial servicesMedical technology and pharmaceuticalsNothing; I'd hoard my cash until the economy improves or View resultsPhotos

10 biggest CEO paychecks

Including salary, bonuses, stock and options, these public company CEOs took home pay packages last year worth up to $104 million. View photos

NEW YORK (CNNMoney.com) -- Stocks inched higher Friday as better-than-expected earnings from Citigroup, General Electric and Google, helped stretch the recent advance to a sixth straight week.

The Dow Jones industrial average (INDU) added 6 points or less than 0.1%. The S&P 500 (SPX) index rose 4 points or 0.5%. Both ended at more than two-month highs.

The Nasdaq composite (COMP) gained 2 points or 0.2%, ending at a more than five-month high.

Stocks, as represented by the S&P 500, have gained 28.5% in the past six weeks, on bets that the economy is closer to stabilizing. The gains followed a selloff that left the S&P 500 at a 12 1/2 year low. A rash of better-than-expected profit reports has helped sentiment this week.

The six week run is the market's best since May 2007, said Ryan Detrick, senior technical strategist at Schaeffer's Investment Research.

"No matter what is thrown at the market, it seems to want to chug higher, which is a big change in psychology from last fall or even earlier this year," Detrick said.

However, he noted that even if the rally proves to be more than a bear market bounce, at six weeks old, it's starting to look ripe for a pullback on a technical basis.

Quarterly results: Citigroup (C, Fortune 500) reported a quarterly profit Friday morning, due to strength in its investment banking division. But after paying out preferred dividends, results amounted to a per-share loss of 18 cents. Nonetheless, that was smaller than the 34-cent per share loss analysts expected. Shares of the Dow component fell 9%.

JPMorgan Chase (JPM, Fortune 500) and Goldman Sachs (GS, Fortune 500) both reported weaker quarterly profit that beat estimates earlier this week. Last week, Wells Fargo (WFC, Fortune 500) forecast that it would report a $3 billion profit.

Regional Bank BB&T (BBT, Fortune 500) reported a weaker quarterly profit that nonetheless handily topped analysts' forecasts. The company also said loan losses are lessening. Shares gained 11%.

Dow component General Electric (GE, Fortune 500) reported weaker quarterly earnings that beat estimates on weaker quarterly sales that missed forecasts. Weakness in the company's finance unit countered mixed results at other divisions. Shares gained 1%.

After the close Thursday, Google (GOOG, Fortune 500) posted quarterly earnings that rose from a year ago and topped estimates on revenue that rose from a year ago but was shy of forecasts. Shares rose 1% Friday morning.

In other company news, General Motors (GM, Fortune 500) CEO Fritz Henderson said that the company will announce more job cuts and plant closings in the next few weeks. The company has until June 1 to reach agreements with its creditors and unions if it wants to avoid a government-mandated bankruptcy. Shares fell 4%.

Market breadth was positive. On the New York Stock Exchange, winners beat losers two to one on volume of 1.95 billion shares. On the Nasdaq, advancers topped decliners eight to five on volume of 2.43 billion shares.

Economy: The April consumer sentiment index from the University of Michigan rose to 61.9 from 57.3 in March. Economists surveyed by Briefing.com thought the index would rise to 58.5.

Bonds: Treasury prices fell, raising the yield on the benchmark 10-year note to 2.94% from 2.83% Thursday. Treasury prices and yields move in opposite directions

TRADE NEWS: Agilent Technologies Completes Large-Scale Expansion of Nucleic Acid Manufacturing Capacity

Submitted by admin on 5/7/2009 @ 8:00 AM

Companies mentioned in this article: Agilent Technologies Inc.

SANTA CLARA, Calif. -- (BUSINESSWIRE) -- Agilent Technologies Inc. (NYSE:A) today announced that a major expansion of its Nucleic Acids Solutions Division (NASD) is complete, enabling the company to manufacture several hundred kilograms of therapeutic oligonucleotides per year. This production capacity allows Agilent to meet customers’ supply needs from preclinical and clinical studies through commercial launch.

Oligonucleotide therapeutics is one of the fastest growing segments in drug development, and NASD’s products are used by biopharmaceutical companies at all stages of drug development. NASD now offers a full range of manufacturing capacities for flexible, cost-efficient production from grams to hundreds of kilograms of oligonucleotide active pharmaceutical ingredients (APIs). This is the second manufacturing expansion of the Boulder, Colo., facility since Agilent purchased the business in 2006, and involves the addition of large scale nucleic acid synthesis, purification and drying capacity.

“We now have the ability to meet our customers’ growing needs with facilities, equipment and expertise across a broad range of nucleic acid APIs,” said James Powell, NASD general manager.

Agilent’s capacity expansion features the addition of a 1 mol synthesizer capable of producing kilo quantities of API per synthesis batch. Equivalent downstream processing including chromatography, ultrafiltration and lyophilization has also been installed. Corresponding infrastructure and reaction vessels were added for custom conjugation chemistries and duplex annealing of siRNAs -- addressing the fastest growth segment of the oligonucleotide market.

About Agilent in Nucleic Acid Therapeutics

Agilent, through its Nucleic Acid Solutions Division, is a leading provider of therapeutic nucleic acid development services and manufacturing solutions for the biotech and pharmaceutical industries. The division operates a 33,500 square foot GMP nucleic acid API contract manufacturing facility in Boulder, Colo. The state-of-the-art facility is capable of manufacturing hundreds of kilos of therapeutic nucleic acid API annually. The broad expertise of a world-class team of employees enables the division to manufacture a wide range of nucleic acid therapeutics, including phosphorothioates, mixed PO/PSs, aptamers, conjugated aptamers, and siRNA. Agilent also offers an array of turnkey services, including development of analytical methods and processes, stability studies, and regulatory support. Information about Agilent’s Nucleic Acid Solutions Division is available at www.agilent.com/chem/nucleicacid.

About Agilent Technologies

Agilent Technologies Inc. (NYSE:A) is the world’s premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company’s 19,000 employees serve customers in more than 110 countries. Agilent had net revenues of $5.8 billion in fiscal 2008. Information about Agilent is available on the Web at www.agilent.com.

NASD Securities licensing product series 7, series 6, series 63, series 9,series 10,series 66, series 65, series 62, series 55, series 26 & series 24,securities licensing,obtaining securities license, securities books,Online training courses,Online certification classes